```json
{
"content": [
{
"type": "paragraph",
"content": "The Non-woven Dressing ecosystem spans upstream raw material production, midstream manufacturing, and downstream healthcare delivery. Value is generated through the integration of polymer science, textile engineering, and clinical applications, with participants collaborating to meet regulatory and clinical standards. The ecosystem is shaped by technological innovation, supply chain dynamics, and end-user demand in wound care management."
},
{
"type": "list",
"items": [
{ "text": "Raw material suppliers — supply polymers, fibers, and adhesives for non-woven substrate production", "level": 1 },
{ "text": "Non-woven fabric manufacturers — produce spunbond, meltblown, or carded fabrics for dressing components", "level": 1 },
{ "text": "Technology providers — develop machinery and processes for non-woven fabrication and sterilization", "level": 1 },
{ "text": "OEMs/contract manufacturers — assemble and package finished non-woven dressings under brand or private labels", "level": 1 },
{ "text": "Distributors/channel partners — facilitate B2B distribution to hospitals, clinics, and pharmacies", "level": 1 },
{ "text": "Healthcare providers — evaluate and adopt dressings based on clinical efficacy and cost parameters", "level": 1 },
{ "text": "Regulatory bodies — enforce quality standards (e.g., ISO, FDA) and certification for market access", "level": 1 }
]
},
{
"type": "paragraph",
"content": "Control points reside with regulators, who define compliance criteria, and raw material suppliers, whose pricing and availability impact production costs. Dependency risks include supply chain disruptions for critical polymers and stringent approval cycles affecting time-to-market. Switching costs are moderate for manufacturers due to equipment specialization, while interoperability in healthcare settings is driven by standardization requirements across packaging, labeling, and application protocols."
}
]
}
```
